Form 8-K - Current report:
SEC Accession No. 0001564590-21-025293
Filing Date
2021-05-07
Accepted
2021-05-07 07:00:25
Documents
14
Period of Report
2021-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rdus-8k_20210507.htm   iXBRL 8-K 39444
2 EX-99.1 rdus-ex991_6.htm EX-99.1 427582
3 GRAPHIC gouckwjo3cs2000001.jpg GRAPHIC 36793
  Complete submission text file 0001564590-21-025293.txt   670302

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA rdus-20210507.xsd EX-101.SCH 5788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE rdus-20210507_lab.xml EX-101.LAB 19473
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rdus-20210507_pre.xml EX-101.PRE 11639
7 EXTRACTED XBRL INSTANCE DOCUMENT rdus-8k_20210507_htm.xml XML 3552
Mailing Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451
Business Address ATTN: CHIEF FINANCIAL OFFICER 950 WINTER STREET WALTHAM MA 02451 617-551-4000
Radius Health, Inc. (Filer) CIK: 0001428522 (see all company filings)

EIN.: 800145732 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35726 | Film No.: 21900177
SIC: 2834 Pharmaceutical Preparations